Chinese Acute Ischemic Stroke Treatment Outcome Registry

Chinese Acute Ischemic Stroke Treatment Outcome Registry

This is a multi-center registry study. The investigators will include 10,000 patients with confirmed acute ischemic stroke in China. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

Stroke is a common disease in China. Compared to western countries, there are many treatment regimens used in clinical practice in China. But their treatment effects are not well validated. The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.

Inclusion Criteria:

1. age ≥18 yesrs
2. confirmed diagnosis of an ischemic stroke
3. admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
4. signed informed consent

Exclusion Criteria:

1. with intracerebral hemorrhage
2. with severe morbid (estimated survival duration less than 3 months)
3. could not provide follow-up information